Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 2700 entries
Sorted by: Best Match Show Resources per page
Broadly tunable subterahertz emission from internal branches of the current-voltage characteristics of superconducting Bi2Sr2CaCu2O(8+δ) single crystals.

Physical review letters

Tsujimoto M, Yamamoto T, Delfanazari K, Nakayama R, Kitamura T, Sawamura M, Kashiwagi T, Minami H, Tachiki M, Kadowaki K, Klemm RA.
PMID: 22463446
Phys Rev Lett. 2012 Mar 09;108(10):107006. doi: 10.1103/PhysRevLett.108.107006. Epub 2012 Mar 09.

Continuous, coherent subterahertz radiation arises when a dc voltage is applied across a stack of the many intrinsic Josephson junctions in a Bi2Sr2CaCu2O(8+δ) single crystal. The active junctions produce an equal number of I-V characteristic branches. Each branch radiates...

Cite
Tsujimoto M, Yamamoto T, Delfanazari K, et al. Broadly tunable subterahertz emission from internal branches of the current-voltage characteristics of superconducting Bi2Sr2CaCu2O(8+δ) single crystals. Phys Rev Lett. 2012;108(10):107006doi: 10.1103/PhysRevLett.108.107006.
Tsujimoto, M., Yamamoto, T., Delfanazari, K., Nakayama, R., Kitamura, T., Sawamura, M., Kashiwagi, T., Minami, H., Tachiki, M., Kadowaki, K., & Klemm, R. A. (2012). Broadly tunable subterahertz emission from internal branches of the current-voltage characteristics of superconducting Bi2Sr2CaCu2O(8+δ) single crystals. Physical review letters, 108(10), 107006. https://doi.org/10.1103/PhysRevLett.108.107006
Tsujimoto, Manabu, et al. "Broadly tunable subterahertz emission from internal branches of the current-voltage characteristics of superconducting Bi2Sr2CaCu2O(8+δ) single crystals." Physical review letters vol. 108,10 (2012): 107006. doi: https://doi.org/10.1103/PhysRevLett.108.107006
Tsujimoto M, Yamamoto T, Delfanazari K, Nakayama R, Kitamura T, Sawamura M, Kashiwagi T, Minami H, Tachiki M, Kadowaki K, Klemm RA. Broadly tunable subterahertz emission from internal branches of the current-voltage characteristics of superconducting Bi2Sr2CaCu2O(8+δ) single crystals. Phys Rev Lett. 2012 Mar 09;108(10):107006. doi: 10.1103/PhysRevLett.108.107006. Epub 2012 Mar 09. PMID: 22463446.
Copy Download .nbib Format: NLM
Ultraslow convergence to ergodicity in transient subdiffusion.

Physical review. E, Statistical, nonlinear, and soft matter physics

Miyaguchi T, Akimoto T.
PMID: 21797421
Phys Rev E Stat Nonlin Soft Matter Phys. 2011 Jun;83(6):062101. doi: 10.1103/PhysRevE.83.062101. Epub 2011 Jun 15.

We investigate continuous time random walks with truncated α-stable trapping times. We prove distributional ergodicity for a class of observables; namely, the time-averaged observables follow the probability density function called the Mittag-Leffler distribution. This distributional ergodic behavior persists for...

Cite
Miyaguchi T, Akimoto T. Ultraslow convergence to ergodicity in transient subdiffusion. Phys Rev E Stat Nonlin Soft Matter Phys. 2011;83(6):062101doi: 10.1103/PhysRevE.83.062101.
Miyaguchi, T., & Akimoto, T. (2011). Ultraslow convergence to ergodicity in transient subdiffusion. Physical review. E, Statistical, nonlinear, and soft matter physics, 83(6), 062101. https://doi.org/10.1103/PhysRevE.83.062101
Miyaguchi, Tomoshige, and Akimoto, Takuma. "Ultraslow convergence to ergodicity in transient subdiffusion." Physical review. E, Statistical, nonlinear, and soft matter physics vol. 83,6 (2011): 062101. doi: https://doi.org/10.1103/PhysRevE.83.062101
Miyaguchi T, Akimoto T. Ultraslow convergence to ergodicity in transient subdiffusion. Phys Rev E Stat Nonlin Soft Matter Phys. 2011 Jun;83(6):062101. doi: 10.1103/PhysRevE.83.062101. Epub 2011 Jun 15. PMID: 21797421.
Copy Download .nbib Format: NLM
A case of ecchordosis physaliphora presenting with an abducens nerve palsy: A rare symptomatic case managed with endoscopic endonasal transsphenoidal surgery.

Surgical neurology international

Yamamoto T, Yano S, Hide T, Kuratsu J.
PMID: 23493306
Surg Neurol Int. 2013;4:13. doi: 10.4103/2152-7806.106562. Epub 2013 Jan 28.

BACKGROUND: Ecchordosis physaliphora (EP) is a benign notochordal remnant that is usually asymptomatic; symptomatic cases are extremely rare. Most of the reported symptomatic cases were managed by resection via craniotomy.CASE DESCRIPTION: We report a case of a 20-year-old male...

Cite
Yamamoto T, Yano S, Hide T, et al. A case of ecchordosis physaliphora presenting with an abducens nerve palsy: A rare symptomatic case managed with endoscopic endonasal transsphenoidal surgery. Surg Neurol Int. 2013;4:13doi: 10.4103/2152-7806.106562.
Yamamoto, T., Yano, S., Hide, T., & Kuratsu, J. (2013). A case of ecchordosis physaliphora presenting with an abducens nerve palsy: A rare symptomatic case managed with endoscopic endonasal transsphenoidal surgery. Surgical neurology international, 413. https://doi.org/10.4103/2152-7806.106562
Yamamoto, Takahiro, et al. "A case of ecchordosis physaliphora presenting with an abducens nerve palsy: A rare symptomatic case managed with endoscopic endonasal transsphenoidal surgery." Surgical neurology international vol. 4 (2013): 13. doi: https://doi.org/10.4103/2152-7806.106562
Yamamoto T, Yano S, Hide T, Kuratsu J. A case of ecchordosis physaliphora presenting with an abducens nerve palsy: A rare symptomatic case managed with endoscopic endonasal transsphenoidal surgery. Surg Neurol Int. 2013;4:13. doi: 10.4103/2152-7806.106562. Epub 2013 Jan 28. PMID: 23493306; PMCID: PMC3589834.
Copy Download .nbib Format: NLM
Bilateral corticosteroid-induced osteonecrosis of the femoral head detected at a 6-week interval.

SpringerPlus

Sonoda K, Yamamoto T, Motomura G, Hamai S, Karasuyama K, Kubo Y, Iwamoto Y.
PMID: 26558165
Springerplus. 2015 Nov 02;4:662. doi: 10.1186/s40064-015-1458-9. eCollection 2015.

INTRODUCTION: Corticosteroid-induced osteonecrosis of the femoral head (ONFH) often affects both femoral heads. Such bilateral ONFH cases are generally detected concurrently on magnetic resonance imaging (MRI). On the other hand, in unilateral cases, it is rare that contralateral ONFH...

Cite
Sonoda K, Yamamoto T, Motomura G, et al. Bilateral corticosteroid-induced osteonecrosis of the femoral head detected at a 6-week interval. Springerplus. 2015;4:662doi: 10.1186/s40064-015-1458-9.
Sonoda, K., Yamamoto, T., Motomura, G., Hamai, S., Karasuyama, K., Kubo, Y., & Iwamoto, Y. (2015). Bilateral corticosteroid-induced osteonecrosis of the femoral head detected at a 6-week interval. SpringerPlus, 4662. https://doi.org/10.1186/s40064-015-1458-9
Sonoda, Kazuhiko, et al. "Bilateral corticosteroid-induced osteonecrosis of the femoral head detected at a 6-week interval." SpringerPlus vol. 4 (2015): 662. doi: https://doi.org/10.1186/s40064-015-1458-9
Sonoda K, Yamamoto T, Motomura G, Hamai S, Karasuyama K, Kubo Y, Iwamoto Y. Bilateral corticosteroid-induced osteonecrosis of the femoral head detected at a 6-week interval. Springerplus. 2015 Nov 02;4:662. doi: 10.1186/s40064-015-1458-9. eCollection 2015. PMID: 26558165; PMCID: PMC4630241.
Copy Download .nbib Format: NLM
Clinicopathological analysis of mechanic's hand associated with dermatomyositis.

The Australasian journal of dermatology

Mori T, Ohashi T, Kato Y, Ohtsuka M, Yamamoto T.
PMID: 26299387
Australas J Dermatol. 2016 Nov;57(4):e123-e126. doi: 10.1111/ajd.12381. Epub 2015 Aug 23.

Mechanic's hand is often seen in the fingers of patients with dermatomyositis and is frequently associated with anti-aminoacyl-transfer RNA synthetase autoantibodies and interstitial lung disease. We analysed the clinical symptoms of 50 patients with dermatomyositis who had visited our...

Cite
Mori T, Ohashi T, Kato Y, et al. Clinicopathological analysis of mechanic's hand associated with dermatomyositis. Australas J Dermatol. 2015;57(4):e123-e126doi: 10.1111/ajd.12381.
Mori, T., Ohashi, T., Kato, Y., Ohtsuka, M., & Yamamoto, T. (2016). Clinicopathological analysis of mechanic's hand associated with dermatomyositis. The Australasian journal of dermatology, 57(4), e123-e126. https://doi.org/10.1111/ajd.12381
Mori, Tatsuhiko, et al. "Clinicopathological analysis of mechanic's hand associated with dermatomyositis." The Australasian journal of dermatology vol. 57,4 (2016): e123-e126. doi: https://doi.org/10.1111/ajd.12381
Mori T, Ohashi T, Kato Y, Ohtsuka M, Yamamoto T. Clinicopathological analysis of mechanic's hand associated with dermatomyositis. Australas J Dermatol. 2016 Nov;57(4):e123-e126. doi: 10.1111/ajd.12381. Epub 2015 Aug 23. PMID: 26299387.
Copy Download .nbib Format: NLM
Development and characterization of 27 microsatellite markers for the mangrove fern, Acrostichum aureum (Pteridaceae).

Applications in plant sciences

Yamamoto T, Tsuda Y, Mori GM, Cruz MV, Shinmura Y, Wee AK, Takayama K, Asakawa T, Yamakawa T, Suleiman M, Núñez-Farfán J, Webb EL, Watano Y, Kajita T.
PMID: 27672519
Appl Plant Sci. 2016 Sep 19;4(9). doi: 10.3732/apps.1600042. eCollection 2016 Sep.

PREMISE OF THE STUDY: Twenty-seven nuclear microsatellite markers were developed for the mangrove fern, Acrostichum aureum (Pteridaceae), to investigate the genetic structure and demographic history of the only pantropical mangrove plant.METHODS AND RESULTS: Fifty-six A. aureum individuals from three...

Cite
Yamamoto T, Tsuda Y, Mori GM, et al. Development and characterization of 27 microsatellite markers for the mangrove fern, Acrostichum aureum (Pteridaceae). Appl Plant Sci. 2016;4(9)doi: 10.3732/apps.1600042.
Yamamoto, T., Tsuda, Y., Mori, G. M., Cruz, M. V., Shinmura, Y., Wee, A. K., Takayama, K., Asakawa, T., Yamakawa, T., Suleiman, M., Núñez-Farfán, J., Webb, E. L., Watano, Y., & Kajita, T. (2016). Development and characterization of 27 microsatellite markers for the mangrove fern, Acrostichum aureum (Pteridaceae). Applications in plant sciences, 4(9), . https://doi.org/10.3732/apps.1600042
Yamamoto, Takashi, et al. "Development and characterization of 27 microsatellite markers for the mangrove fern, Acrostichum aureum (Pteridaceae)." Applications in plant sciences vol. 4,9 (2016). doi: https://doi.org/10.3732/apps.1600042
Yamamoto T, Tsuda Y, Mori GM, Cruz MV, Shinmura Y, Wee AK, Takayama K, Asakawa T, Yamakawa T, Suleiman M, Núñez-Farfán J, Webb EL, Watano Y, Kajita T. Development and characterization of 27 microsatellite markers for the mangrove fern, Acrostichum aureum (Pteridaceae). Appl Plant Sci. 2016 Sep 19;4(9). doi: 10.3732/apps.1600042. eCollection 2016 Sep. PMID: 27672519; PMCID: PMC5033363.
Copy Download .nbib Format: NLM
Organophosphate Poisoning and Terrorism.

The Malaysian journal of medical sciences : MJMS

Tanimoto T, Oshima Y, Yuji K, Ozaki A, Kami M.
PMID: 28951697
Malays J Med Sci. 2017 Aug;24(4):111-112. doi: 10.21315/mjms2017.24.4.14. Epub 2017 Aug 18.

No abstract available.

Cite
Tanimoto T, Oshima Y, Yuji K, et al. Organophosphate Poisoning and Terrorism. Malays J Med Sci. 2017;24(4):111-112doi: 10.21315/mjms2017.24.4.14.
Tanimoto, T., Oshima, Y., Yuji, K., Ozaki, A., & Kami, M. (2017). Organophosphate Poisoning and Terrorism. The Malaysian journal of medical sciences : MJMS, 24(4), 111-112. https://doi.org/10.21315/mjms2017.24.4.14
Tanimoto, Tetsuya, et al. "Organophosphate Poisoning and Terrorism." The Malaysian journal of medical sciences : MJMS vol. 24,4 (2017): 111-112. doi: https://doi.org/10.21315/mjms2017.24.4.14
Tanimoto T, Oshima Y, Yuji K, Ozaki A, Kami M. Organophosphate Poisoning and Terrorism. Malays J Med Sci. 2017 Aug;24(4):111-112. doi: 10.21315/mjms2017.24.4.14. Epub 2017 Aug 18. PMID: 28951697; PMCID: PMC5609697.
Copy Download .nbib Format: NLM
Rationale, Design, and Baseline Characteristics of the Utopia Trial for Preventing Diabetic Atherosclerosis Using an SGLT2 Inhibitor: A Prospective, Randomized, Open-Label, Parallel-Group Comparative Study.

Diabetes therapy : research, treatment and education of diabetes and related disorders

Katakami N, Mita T, Yoshii H, Shiraiwa T, Yasuda T, Okada Y, Umayahara Y, Kaneto H, Osonoi T, Yamamoto T, Kuribayashi N, Maeda K, Yokoyama H, Kosugi K, Ohtoshi K, Hayashi I, Sumitani S, Tsugawa M, Ohashi M, Taki H, Nakamura T, Kawashima S, Sato Y, Watada H, Shimomura I.
PMID: 28864997
Diabetes Ther. 2017 Oct;8(5):999-1013. doi: 10.1007/s13300-017-0292-1. Epub 2017 Sep 01.

INTRODUCTION: Sodium-glucose co-transporter-2 (SGLT2) inhibitors are anti-diabetic agents that improve glycemic control with a low risk of hypoglycemia and ameliorate a variety of cardiovascular risk factors. The aim of the ongoing study described herein is to investigate the preventive...

Cite
Katakami N, Mita T, Yoshii H, et al. Rationale, Design, and Baseline Characteristics of the Utopia Trial for Preventing Diabetic Atherosclerosis Using an SGLT2 Inhibitor: A Prospective, Randomized, Open-Label, Parallel-Group Comparative Study. Diabetes Ther. 2017;8(5):999-1013doi: 10.1007/s13300-017-0292-1.
Katakami, N., Mita, T., Yoshii, H., Shiraiwa, T., Yasuda, T., Okada, Y., Umayahara, Y., Kaneto, H., Osonoi, T., Yamamoto, T., Kuribayashi, N., Maeda, K., Yokoyama, H., Kosugi, K., Ohtoshi, K., Hayashi, I., Sumitani, S., Tsugawa, M., Ohashi, M., Taki, H., Nakamura, T., Kawashima, S., Sato, Y., Watada, H., Shimomura, I. (2017). Rationale, Design, and Baseline Characteristics of the Utopia Trial for Preventing Diabetic Atherosclerosis Using an SGLT2 Inhibitor: A Prospective, Randomized, Open-Label, Parallel-Group Comparative Study. Diabetes therapy : research, treatment and education of diabetes and related disorders, 8(5), 999-1013. https://doi.org/10.1007/s13300-017-0292-1
Katakami, Naoto, et al. "Rationale, Design, and Baseline Characteristics of the Utopia Trial for Preventing Diabetic Atherosclerosis Using an SGLT2 Inhibitor: A Prospective, Randomized, Open-Label, Parallel-Group Comparative Study." Diabetes therapy : research, treatment and education of diabetes and related disorders vol. 8,5 (2017): 999-1013. doi: https://doi.org/10.1007/s13300-017-0292-1
Katakami N, Mita T, Yoshii H, Shiraiwa T, Yasuda T, Okada Y, Umayahara Y, Kaneto H, Osonoi T, Yamamoto T, Kuribayashi N, Maeda K, Yokoyama H, Kosugi K, Ohtoshi K, Hayashi I, Sumitani S, Tsugawa M, Ohashi M, Taki H, Nakamura T, Kawashima S, Sato Y, Watada H, Shimomura I. Rationale, Design, and Baseline Characteristics of the Utopia Trial for Preventing Diabetic Atherosclerosis Using an SGLT2 Inhibitor: A Prospective, Randomized, Open-Label, Parallel-Group Comparative Study. Diabetes Ther. 2017 Oct;8(5):999-1013. doi: 10.1007/s13300-017-0292-1. Epub 2017 Sep 01. PMID: 28864997; PMCID: PMC5630549.
Copy Download .nbib Format: NLM
Feasibility of cognitive remediation therapy for adults with autism spectrum disorders: a single-group pilot study.

Neuropsychiatric disease and treatment

Okuda T, Asano K, Numata N, Hirano Y, Yamamoto T, Tanaka M, Matsuzawa D, Shimizu E, Iyo M, Nakazato M.
PMID: 28860776
Neuropsychiatr Dis Treat. 2017 Aug 16;13:2185-2191. doi: 10.2147/NDT.S141555. eCollection 2017.

BACKGROUND: Set-shifting (SS) difficulties and weak central coherence (CC) are commonly associated with autism spectrum disorders (ASD). Cognitive remediation therapy (CRT) aims to improve such cognitive processing; however, there are no reports on CRT for patients with ASD. This...

Cite
Okuda T, Asano K, Numata N, et al. Feasibility of cognitive remediation therapy for adults with autism spectrum disorders: a single-group pilot study. Neuropsychiatr Dis Treat. 2017;13:2185-2191doi: 10.2147/NDT.S141555.
Okuda, T., Asano, K., Numata, N., Hirano, Y., Yamamoto, T., Tanaka, M., Matsuzawa, D., Shimizu, E., Iyo, M., & Nakazato, M. (2017). Feasibility of cognitive remediation therapy for adults with autism spectrum disorders: a single-group pilot study. Neuropsychiatric disease and treatment, 132185-2191. https://doi.org/10.2147/NDT.S141555
Okuda, Tomoko, et al. "Feasibility of cognitive remediation therapy for adults with autism spectrum disorders: a single-group pilot study." Neuropsychiatric disease and treatment vol. 13 (2017): 2185-2191. doi: https://doi.org/10.2147/NDT.S141555
Okuda T, Asano K, Numata N, Hirano Y, Yamamoto T, Tanaka M, Matsuzawa D, Shimizu E, Iyo M, Nakazato M. Feasibility of cognitive remediation therapy for adults with autism spectrum disorders: a single-group pilot study. Neuropsychiatr Dis Treat. 2017 Aug 16;13:2185-2191. doi: 10.2147/NDT.S141555. eCollection 2017. PMID: 28860776; PMCID: PMC5565247.
Copy Download .nbib Format: NLM
Serum calcitriol levels in a patient with X-linked hypophosphatemia complicated by autosomal dominant polycystic kidney disease.

CEN case reports

Kajita S, Yamamoto T, Tsugawa N, Nakayama H, Kubota T, Michigami T, Ozono K.
PMID: 28509123
CEN Case Rep. 2017 May;6(1):29-35. doi: 10.1007/s13730-016-0238-x. Epub 2016 Oct 22.

Serum calcitriol [1,25(OH)

Cite
Kajita S, Yamamoto T, Tsugawa N, et al. Serum calcitriol levels in a patient with X-linked hypophosphatemia complicated by autosomal dominant polycystic kidney disease. CEN Case Rep. 2016;6(1):29-35doi: 10.1007/s13730-016-0238-x.
Kajita, S., Yamamoto, T., Tsugawa, N., Nakayama, H., Kubota, T., Michigami, T., & Ozono, K. (2017). Serum calcitriol levels in a patient with X-linked hypophosphatemia complicated by autosomal dominant polycystic kidney disease. CEN case reports, 6(1), 29-35. https://doi.org/10.1007/s13730-016-0238-x
Kajita, Satomi, et al. "Serum calcitriol levels in a patient with X-linked hypophosphatemia complicated by autosomal dominant polycystic kidney disease." CEN case reports vol. 6,1 (2017): 29-35. doi: https://doi.org/10.1007/s13730-016-0238-x
Kajita S, Yamamoto T, Tsugawa N, Nakayama H, Kubota T, Michigami T, Ozono K. Serum calcitriol levels in a patient with X-linked hypophosphatemia complicated by autosomal dominant polycystic kidney disease. CEN Case Rep. 2017 May;6(1):29-35. doi: 10.1007/s13730-016-0238-x. Epub 2016 Oct 22. PMID: 28509123; PMCID: PMC5438803.
Copy Download .nbib Format: NLM
Novel SLC16A2 mutations in patients with Allan-Herndon-Dudley syndrome.

Intractable & rare diseases research

Shimojima K, Maruyama K, Kikuchi M, Imai A, Inoue K, Yamamoto T.
PMID: 27672545
Intractable Rare Dis Res. 2016 Aug;5(3):214-7. doi: 10.5582/irdr.2016.01051.

Allan-Herndon-Dudley syndrome (AHDS) is an X-linked disorder caused by impaired thyroid hormone transporter. Patients with AHDS usually exhibit severe motor developmental delay, delayed myelination of the brain white matter, and elevated T3 levels in thyroid tests. Neurological examination of...

Cite
Shimojima K, Maruyama K, Kikuchi M, et al. Novel SLC16A2 mutations in patients with Allan-Herndon-Dudley syndrome. Intractable Rare Dis Res. 2016;5(3):214-7doi: 10.5582/irdr.2016.01051.
Shimojima, K., Maruyama, K., Kikuchi, M., Imai, A., Inoue, K., & Yamamoto, T. (2016). Novel SLC16A2 mutations in patients with Allan-Herndon-Dudley syndrome. Intractable & rare diseases research, 5(3), 214-7. https://doi.org/10.5582/irdr.2016.01051
Shimojima, Keiko, et al. "Novel SLC16A2 mutations in patients with Allan-Herndon-Dudley syndrome." Intractable & rare diseases research vol. 5,3 (2016): 214-7. doi: https://doi.org/10.5582/irdr.2016.01051
Shimojima K, Maruyama K, Kikuchi M, Imai A, Inoue K, Yamamoto T. Novel SLC16A2 mutations in patients with Allan-Herndon-Dudley syndrome. Intractable Rare Dis Res. 2016 Aug;5(3):214-7. doi: 10.5582/irdr.2016.01051. PMID: 27672545; PMCID: PMC4995413.
Copy Download .nbib Format: NLM
SU-E-J-31: Direct Point Dose Verification Using IGRT for Actual Beam Delivery.

Medical physics

Matsubara K, Kohno R, Nishioka S, Shibuya T, Ariji T, Akimoto T, Saitoh H.
PMID: 28517591
Med Phys. 2012 Jun;39(6):3659. doi: 10.1118/1.4734864.

PURPOSE: In radiation therapy, treatment planning for patients is performed using pre-acquired CT images. However, many patients with head-and-neck (H&N) cancer have tumor shrinkage and/or weight loss during their treatment course. Daily positional error of patients also causes unexpected...

Cite
Matsubara K, Kohno R, Nishioka S, et al. SU-E-J-31: Direct Point Dose Verification Using IGRT for Actual Beam Delivery. Med Phys. 2012;39(6):3659doi: 10.1118/1.4734864.
Matsubara, K., Kohno, R., Nishioka, S., Shibuya, T., Ariji, T., Akimoto, T., & Saitoh, H. (2012). SU-E-J-31: Direct Point Dose Verification Using IGRT for Actual Beam Delivery. Medical physics, 39(6), 3659. https://doi.org/10.1118/1.4734864
Matsubara, K, et al. "SU-E-J-31: Direct Point Dose Verification Using IGRT for Actual Beam Delivery." Medical physics vol. 39,6 (2012): 3659. doi: https://doi.org/10.1118/1.4734864
Matsubara K, Kohno R, Nishioka S, Shibuya T, Ariji T, Akimoto T, Saitoh H. SU-E-J-31: Direct Point Dose Verification Using IGRT for Actual Beam Delivery. Med Phys. 2012 Jun;39(6):3659. doi: 10.1118/1.4734864. PMID: 28517591.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 2700 entries